A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E Mutated Differentiated thyroid Cancer - Leboulleux, S; Cao, CD; Zerdoud, S (Clin Cancer Res, 2023)
et al.